Alliance Pharma plc

APH

GB0031030819

Pharmaceuticals

Delayed London S.E. Other stock markets 05:06:14 2024-06-27 EDT			5-day change	1st Jan Change
40.32 ^GBX	+2.85%		-0.45%	-0.45%

06-19	Alliance Pharma pays no dividend as board focus on reinvesting cash	AN
06-19	Transcript : Alliance Pharma plc, 2023 Earnings Call, Jun 19, 2024

Alliance Pharma plc Provides Preliminary Results for the Year Ended 31 December 2023

June 19, 2024 at 02:00 am

Alliance Pharma plc provided preliminary results for the year ended 31 December 2023. For the period, the company reported Revenue of £180.7 million as compared to £167.4 million.

Latest news about Alliance Pharma plc

Alliance Pharma pays no dividend as board focus on reinvesting cash	06-19	AN
Transcript : Alliance Pharma plc, 2023 Earnings Call, Jun 19, 2024	06-19
Alliance Pharma plc Provides Preliminary Results for the Year Ended 31 December 2023	06-19	CI
Alliance Pharma plc Reports Earnings Results for the Full Year Ended December 31, 2023	06-19	CI
Amberen, Brand of Alliance Pharma plc, Announces Launch of Amberen ENERGY MOOD SLEEP Gummies	05-30	CI
Alliance Pharma plc Announces the Appointment of Nicholas John Sedgwick as Director	05-20	CI
Alliance Pharma drops as CEO departs, delays results again	05-09	AN
European Equities Close Higher in Wednesday Trading; Siemens Energy, Alliance Pharma CEOs to Step Down	05-08	MT
Alliance Pharma Chief Executive to Leave; New CEO to Start May 13	05-08	MT
AIM WINNERS & LOSERS: Mobile Tornado wins deal; boohoo loss widens	05-08	AN
Alliance Pharma plc Announces CEO Changes	05-08	CI
Jefferies cuts AJ Bell; Deutsche likes ConvaTec	05-03	AN
EARNINGS: Lok'n Store has "positive but muted" growth as Shurgard bids	04-22	AN
Alliance Pharma plc Announces Delay in Publication of Preliminary Earnings Results for the Year Ended December 31, 2023	04-22	CI
Alliance Pharma appoints chair; FireAngel sales down	02-05	AN
Alliance Pharma Chair to Step Down; Successor Named	02-05	MT
Alliance Pharma plc Announces Board Changes	02-05	CI
Jefferies raises Spirax-Sarco; cuts Victrex	01-31	AN
Alliance Pharma reports annual boost in revenue; eyes flat 2024 profit	01-29	AN
Alliance Pharma plc Announces Appointment of Non-Executive Directors	11-07	CI
Barclays ups Rio Tinto; Liberum likes Indivior	23-10-24	AN
Barclays cuts United Utilities and Severn Trent	23-09-28	AN
Alliance Pharma first half profit plunges, stops dividend payout	23-09-26	AN
Earnings Flash (APH.L) ALLIANCE PHARMA Posts H1 Revenue GBP81.4M	23-09-26	MT
Earnings Flash (APH.L) ALLIANCE PHARMA Posts H1 EPS GBX0.94	23-09-26	MT

Alliance Pharma plc is a United Kingdom-based consumer healthcare company. The principal activity of the Company is to act as a holding company. The principal activity of the Company is the acquisition, marketing and distribution of consumer healthcare and pharmaceutical products. The Company's segments are strategic business units that represent different parts of the overall product portfolio, these being Consumer Healthcare brands and Prescription Medicines. Its Consumer Healthcare brands include Kelo-Cote franchise, Amberen, Nizoral, MacuShield, Aloclair, Vamousse, and other consumer healthcare brands. Its Prescription Medicines include Hydromol, Flamma Franchise, Forceval and other prescription medicines. Its products include Aloclair Plus Gel, Changmin, Fazol Cream, Hydromol Ointment, Kelo-Stretch Cream, and others. It holds the marketing rights to around 80 Consumer Healthcare brands and Prescription Medicines, which are sold around the world in more than 100 countries.

Sector

Pharmaceuticals

Calendar

2024-09-23 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Alliance Pharma plc

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.392 GBP

Average target price

0.6243 GBP

Spread / Average Target

+59.26%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
ALLIANCE PHARMA PLC	-0.45%	267M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.89%	43.67B
OTSUKA HOLDINGS CO., LTD.	+26.21%	22.79B
SANDOZ GROUP AG	+20.77%	15.45B
CIPLA LIMITED	+17.96%	14.29B
ZYDUS LIFESCIENCES LIMITED	+53.24%	12.83B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-11.88%	6.52B
ASPEN PHARMACARE HOLDINGS LIMITED	+12.62%	5.59B
STADA ARZNEIMITTEL	-8.87%	5.73B

Generic Pharmaceuticals